Business Context and Reporting Period
Company: Akebia Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 12, 2021
Context: The filing serves as a Regulation FD disclosure to announce that the Company's President and CEO, John P. Butler, will present information at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021. The presentation materials are attached as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding an upcoming investor presentation and does not contain audited or unaudited financial statements.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The document solely references the upcoming dissemination of information contained in the attached presentation.
Guidance, Outlook, and Risks
- Management Commentary: The Company plans to present information at the J.P. Morgan Healthcare Conference and various investor meetings starting January 12, 2021.
- Legal Disclaimers: The information in this Item 7.01 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to liabilities under that section. It shall not be incorporated by reference into any other SEC filings.
- Forward-Looking Statements: The Company undertakes no duty or obligation to update or revise the information contained in this report, though it may do so at management's discretion.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (J.P. Morgan Healthcare Conference Presentation) for specific clinical data, financial outlook, and strategic updates.
- Verify the date and time of the virtual presentation (January 13, 2021, at 2:50 p.m. Eastern Time).
- Confirm that the information in this 8-K is not incorporated by reference into other filings, as explicitly stated in the text.
- Monitor subsequent press releases or SEC filings for any updates or revisions to the information presented.